Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1990 May;49(5):338–339. doi: 10.1136/ard.49.5.338-c

Chondroprotective drugs and osteoarthritis.

P Ghosh
PMCID: PMC1004088  PMID: 2344220

Full text

PDF
338

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellamy N., Buchanan W. W. Outcome measurement in osteoarthritis clinical trials: the case for standardisation. Clin Rheumatol. 1984 Sep;3(3):293–303. doi: 10.1007/BF02032334. [DOI] [PubMed] [Google Scholar]
  2. Doherty M. 'Chondroprotection' by non-steroidal anti-inflammatory drugs. Ann Rheum Dis. 1989 Aug;48(8):619–621. doi: 10.1136/ard.48.8.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Doherty M. 'Chondroprotection' by non-steroidal anti-inflammatory drugs. Ann Rheum Dis. 1989 Aug;48(8):619–621. doi: 10.1136/ard.48.8.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ghosh P., Wells C., Smith M., Hutadilok N. Chondroprotection, myth or reality: an experimental approach. Semin Arthritis Rheum. 1990 Feb;19(4 Suppl 1):3–9. doi: 10.1016/0049-0172(90)90078-t. [DOI] [PubMed] [Google Scholar]
  5. Heinegård D., Inerot S., Wieslander J., Lindblad G. A method for the quantification of cartilage proteoglycan structures liberated to the synovial fluid during developing degenerative joint disease. Scand J Clin Lab Invest. 1985 Sep;45(5):421–427. doi: 10.1080/00365518509155238. [DOI] [PubMed] [Google Scholar]
  6. Liang M. H., Cullen K. E., Larson M. G. Measuring function and health status in rheumatic disease clinical trials. Clin Rheum Dis. 1983 Dec;9(3):531–539. [PubMed] [Google Scholar]
  7. Lohmander L. S., Dahlberg L., Ryd L., Heinegård D. Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum. 1989 Nov;32(11):1434–1442. doi: 10.1002/anr.1780321113. [DOI] [PubMed] [Google Scholar]
  8. Pattrick M., Aldridge S., Hamilton E., Manhire A., Doherty M. A controlled study of hand function in nodal and erosive osteoarthritis. Ann Rheum Dis. 1989 Dec;48(12):978–982. doi: 10.1136/ard.48.12.978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sabiston C. P., Adams M. E., Li D. K. Magnetic resonance imaging of osteoarthritis: correlation with gross pathology using an experimental model. J Orthop Res. 1987;5(2):164–172. doi: 10.1002/jor.1100050203. [DOI] [PubMed] [Google Scholar]
  10. Sweet M. B., Coelho A., Schnitzler C. M., Schnitzer T. J., Lenz M. E., Jakim I., Kuettner K. E., Thonar E. J. Serum keratan sulfate levels in osteoarthritis patients. Arthritis Rheum. 1988 May;31(5):648–652. doi: 10.1002/art.1780310510. [DOI] [PubMed] [Google Scholar]
  11. Thonar E. J., Lenz M. E., Klintworth G. K., Caterson B., Pachman L. M., Glickman P., Katz R., Huff J., Kuettner K. E. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum. 1985 Dec;28(12):1367–1376. doi: 10.1002/art.1780281209. [DOI] [PubMed] [Google Scholar]
  12. Williamson J. W. Evaluating quality of patient care. A strategy relating outcome and process assessment. JAMA. 1971 Oct 25;218(4):564–569. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES